AUA 2011 Annual Meeting Coverage - Renal and Urology News

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Follow our live coverage from the American Urological Association's 2011 Annual Meeting in Washington, D.C., including our four blogs below that are updated with multiple stories daily.

Sections: Benign Prostatic Hyperplasia (BPH) | Overactive Bladder (OAB)
Prostate Cancer | General News

PCA3 May Help Predict Insignificant Prostate Cancer

John Schieszer June 28, 2011

WASHINGTON, D.C.—Prostate cancer gene 3 (PCA3) may be a valuable predictor of pathologically confirmed low volume disease and insignificant prostate cancer (PCa), according to a study presented at the 2011 annual meeting of the American Urological Association.

Underarm Testosterone Therapy Cleared

John Schieszer June 28, 2011

WASHINGTON, D.C.—The FDA has approved the first and only testosterone therapy applied to the underarm.

Primary Care Providers Ordering More PSA Tests

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—The rate of office-based PSA testing by primary care providers (PCPs) in the United States doubled from 1997 to 2008, according to data presented at the American Urological Association 2011 annual meeting.

Abnormal DREs in Obese Men Predict Greater Risk of Prostate Cancer

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Obese men are less likely to have an abnormal digital rectal examination (DRE) than non-obese men, according to findings presented at the American Urological Association 2011 annual meeting.

Heavier Men Face Higher LUTS Risk

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Elderly men who are overweight or obese are at increased risk for developing lower urinary tract symptoms (LUTS), but those who engage in a relatively high level of physical activity or daily walking for exercise have a reduced risk, data show.

Severe Adverse BPH Outcomes Persist

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Severe adverse outcomes of benign prostatic hyperplasia (BPH) persist despite widespread use of oral therapies, according to a study presented at the American Urological Association 2011 annual meeting.

Trigonal Injections of Botulinum Toxin Improve OAB Outcomes

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Trigonal intradetrusor injections of botulinum toxin-A (BTX-A) results in greater reduction in overactive bladder (OAB) symptoms compared with trigone-sparing BTX-A injections, Irish investigators reported at the American Urological Association 2011 annual meeting.

Statins May Reduce Stone Risk

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Statin use by hyperlipidemic patients may decrease the risk of urinary stone formation, according to study findings presented at the American Urological Association 2011 annual meeting.

Silodosin Found to Ease CP/CPPS Symptoms

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Silodosin may be an effective treatment for moderate or severe chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), researchers reported at the American Urological Association 2011 annual meeting.

Adjuvant Drugs May Aid Clearance of Some Stones

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Adjuvant use of tamsulosin or nifedipine after extracorporeal shock wave lithotripsy (SWL) improves stone free rates in patients treated for non-lower pole renal stones 10-20 mm in diameter, Brazilian researchers reported at the American Urological Association 2011 annual meeting.